Moderna (MRNA) Prices 26.276M Share IPO at $23/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- Six Flags to move headquarters from Charlotte to Arlington, Texas
Moderna to raise $604 million in upsized IPO, braving market jitters
December 6, 2018 6:35 PM ESTBy Lance Tupper and Joshua Franklin
(Reuters) - Moderna Inc (OTC: MRNA) will sell around $604.3 million in shares in its initial public offering (IPO), the biotech company said on Thursday, braving stock market jitters to sell more stock than originally planned.
In the biggest flotation of a biotechnology company since 2016, Moderna said it would sell roughly 26.3 million shares at $23 per share. Moderna had originally planned to sell 21.7 million shares for between $22 and $24 per share.
Moderna is due to start trading on the Nasdaq on Friday under the ticker... More
Moderna (MRNA) considering upsizing IPO by around 20% - Reuters
December 6, 2018 1:12 PM ESTModerna (MRNA) considering upsizing IPO by around 20% - Reuters
... More